Calendar Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.03 CNY | -1.22% |
|
+1.54% | -4.83% |
Dec. 09 | Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement | MT |
Dec. 05 | GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034 | DJ |
Chart calendar Chongqing Zhifei Biological Products Co., Ltd.
Upcoming events on Chongqing Zhifei Biological Products Co., Ltd.
Past events on Chongqing Zhifei Biological Products Co., Ltd.
2024-10-25 | Q3 2024 Earnings Release |
2024-08-29 | Q2 2024 Earnings Release |
2024-06-17 10:00 pm | Annual General Meeting |
2024-04-22 | Q1 2024 Earnings Release |
2024-04-22 | Q4 2023 Earnings Release |
2024-03-10 10:00 pm | Extraordinary Shareholders Meeting |
2023-11-15 09:00 pm | Extraordinary Shareholders Meeting |
2023-10-26 | Q3 2023 Earnings Release |
2023-08-28 | Q2 2023 Earnings Release |
2023-04-20 02:30 am | Annual General Meeting |
2023-04-19 | Q1 2023 Earnings Release |
2023-03-20 | Q4 2022 Earnings Release |
2022-10-27 | Q3 2022 Earnings Release |
2022-08-29 | Interim 2022 Earnings Release |
2022-05-19 10:00 pm | Annual General Meeting |
2022-04-27 | Q1 2022 Earnings Release |
2022-04-27 | FY 2021 Earnings Release |
2022-02-13 09:30 pm | Extraordinary Shareholders Meeting |
2021-10-28 | Q3 2021 Earnings Release |
2021-09-17 02:30 am | Extraordinary Shareholders Meeting |
Past dividends on Chongqing Zhifei Biological Products Co., Ltd.
2024-12-24 | Interim Payment 0.2 CNY |
2024-08-07 | Annual 0.8 CNY |
2023-06-15 | Annual 0.5 CNY |
2022-07-14 | Annual 0.6 CNY |
2021-08-05 | Annual 0.5 CNY |
2020-08-11 | Annual 0.5 CNY |
2019-06-23 | Annual 0.5 CNY |
2018-06-06 | Annual 0.13 CNY |
2017-05-14 | Annual 0.01 CNY |
2016-05-12 | Annual 0.1 CNY |
2015-05-27 | 0.1 CNY |
2014-05-27 | Annual 0.2 CNY |
2013-05-22 | Annual 0.3 CNY |
2012-04-25 | Annual 0.25 CNY |
2011-04-13 | Annual 0.2 CNY |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 30 637 25 089 22.11% | 38 264 33 290 14.94% | 52 918 49 894 6.06% | 42 114 | 47 525 | 45 584 |
EBITDA Million CNY | Released Forecast Spread | 12 394 7 444 66.49% | 9 079 9 237 -1.71% | 9 700 10 387 -6.62% | 4 289 | 8 616 | 8 574 |
EBIT Million CNY | Released Forecast Spread | 11 986 8 080 48.35% | 8 758 8 675 0.96% | 9 373 10 398 -9.85% | 0,00 | 12 580 | 12 915 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 11 917 8 507 40.09% | 8 718 8 941 -2.5% | 9 342 10 408 -10.24% | 6 991 | 10 644 | 10 044 |
Net income Million CNY | Released Forecast Spread | 10 197 7 452 36.84% | 7 539 7 629 -1.18% | 8 070 8 954 -9.87% | 5 472 | 8 561 | 8 089 |
EPS CNY | Released Forecast Spread | 4,25 3,07 38.26% | 3,14 3,16 -0.7% | 3,36 3,77 -10.75% | 2,23 | 3,51 | 3,27 |
Announcement Date | 08/02/22 | 20/03/23 | 22/04/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 11 173 9 320 19.88% | 13 273 10 896 21.81% | 14 826 12 577 17.88% | 13 646 13 316 2.48% | 11 396 12 481 -8.7% | 6 863 12 794 -46.36% | 4 528 12 756 -64.5% | 4 738 | 7 392 | 8 451 | 9 480 | 10 337 |
EBITDA Million CNY | Released Forecast Spread | 1 951 | 1 793 | 2 776 | 2 776 | 2 482 | 1 913 | 2 381 | 383 | ||||
EBIT Million CNY | Released Forecast Spread | 2 397 2 376 0.87% | 2 711 2 506 8.19% | 2 668 2 614 2.06% | 1 738 2 057 -15.52% | 1 737 2 614 -33.56% | 842 2 730 -69.14% | -94,4 | |||||
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 2 392 1 892 26.44% | 2 570 1 734 48.26% | 2 657 2 682 -0.94% | 1 723 2 682 -35.75% | 1 734 2 403 -27.84% | 839 1 836 -54.3% | -94,7 2 265 -104.18% | 192 | ||||
Net income Million CNY | Released Forecast Spread | 2 032 1 636 24.19% | 2 228 1 499 48.62% | 2 270 2 319 -2.11% | 1 540 2 319 -33.62% | 1 458 2 207 -33.96% | 777 1 560 -50.23% | -83,7 1 948 -104.3% | 198 | ||||
EPS CNY | Released Forecast Spread | 0,85 0,76 11.77% | 0,93 0,79 17.91% | 0,94 0,94 -0.34% | 0,64 0,86 -25.86% | 0,61 0,93 -34.52% | 0,32 0,76 -57.9% | -0,03 0,81 -103.7% | 0,09 | 0,34 | 0,37 | 0,41 | |
Announcement Date | 19/04/23 | 28/08/23 | 26/10/23 | 22/04/24 | 22/04/24 | 29/08/24 | 25/10/24 | - | - | - | - | - |
2025-02-18 07:00 am | AXSOME THERAPEUTICS, INC.: Q4 2024 Earnings Release |
2025-02-19 04:03 pm | BIOMARIN PHARMACEUTICAL INC.: Q4 2024 Earnings Release |
2025-02-19 | BRIDGEBIO PHARMA, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-25 02:00 am | BONESUPPORT HOLDING AB: Q4 2024 Earnings Release |
2025-02-25 | INTRA-CELLULAR THERAPIES, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-25 | CATALYST PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
2025-02-25 | GRIFOLS, S.A.: Q4 2024 Earnings Release |
2025-02-26 | ZAI LAB LIMITED: Q4 2024 Earnings Release |
2025-02-27 01:00 am | UCB: Q4 2024 Earnings Release |
2025-03-02 | PHARMA MAR, S.A.: Q4 2024 Earnings Release (Projected) |
Past sector events for Chongqing Zhifei Biological Products Co., Ltd.
2025-02-13 | NXERA PHARMA CO., LTD.: Q4 2024 Earnings Release |
2025-02-13 08:58 am | CONCORD BIOTECH LIMITED: Q3 2025 Earnings Release |
2025-02-12 | HUGEL, INC.: Q4 2024 Earnings Release |
2025-02-12 02:00 am | BIOGAIA AB: Q4 2024 Earnings Release |
2025-02-11 | BIOGEN INC.: Q4 2024 Earnings Release |
2025-02-11 04:11 pm | CSL LIMITED: Q2 2025 Earnings Release |
2025-02-10 07:00 am | INCYTE CORPORATION: Q4 2024 Earnings Release |
2025-02-10 06:13 am | EIRGENIX INC.: January 2025 Sales and Revenue Release |
2025-02-05 02:00 am | SWEDISH ORPHAN BIOVITRUM AB: Q4 2024 Earnings Release |
2025-02-04 | SK BIOSCIENCE CO.,LTD.: Q4 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300122 Stock
- Calendar Chongqing Zhifei Biological Products Co., Ltd.